Key Laboratory of Cancer Prevention and Intervention of Ministry of Education, Key Laboratory of Molecular Biology in Medical Science of Zhejiang Province, Cancer Institute, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
J Zhejiang Univ Sci B. 2010 Sep;11(9):647-53. doi: 10.1631/jzus.B1000198.
The purpose of this study was to determine the unique and universal features of microsatellite instability-high (MSI-H) colorectal cancer (CRC) and MSI-H gastric cancer (GC) in the Chinese population.
A new panel of mononucleotide MSI markers, BAT25, BAT26, NR21, NR24, and MONO-27, was used to define MSI status in 303 CRC and 288 GC subjects. Clinicopathological features of both types of MSI-H tumors were analyzed. Methylation analysis in the hMLH1 promoter region by methylation specific polymerase chain reaction (PCR) and mutation detection of hMSH2/hMLH1 genes by denaturing high-performance liquid chromatography (DHPLC) were carried out simultaneously.
MSI-H CRCs and MSI-H GCs account for 11.9% and 8.0% of unselected sporadic CRCs and GCs, respectively. MSI-H CRCs are strongly characterized by early onset, right-side location, low differentiation, mucinous tumor, less infiltration, less lymphatic metastasis, and more often familial tumor. MSI-H GCs only showed site preference for the antrum and less lymphatic metastasis. Genetic and epigenetic analyses were positive in 6/36 MSI-H CRCs and 0/23 MSI-H GCs with pathological mutation in major mismatch repair genes, and in 7/36 MSI-H CRCs and 18/23 MSI-H GCs with methylated hMLH1 promoter (P<0.01), respectively.
Although there are many differences in the genetic basis and clinicopathological features between MSI-H CRC and MSI-H GC, when compared with their microsatellite stable (MSS) counterparts, site preference and lymphatic metastasis are features common to both types of MSI-H tumors.
本研究旨在确定中国人群中微卫星不稳定高(MSI-H)结直肠癌(CRC)和 MSI-H 胃癌(GC)的独特和普遍特征。
使用新的单核苷酸 MSI 标记物 BAT25、BAT26、NR21、NR24 和 MONO-27 对 303 例 CRC 和 288 例 GC 患者进行 MSI 状态定义。分析两种 MSI-H 肿瘤的临床病理特征。同时进行 hMLH1 启动子区域的甲基化分析,采用甲基化特异性聚合酶链反应(PCR),hMSH2/hMLH1 基因突变检测采用变性高效液相色谱(DHPLC)。
MSI-H CRC 和 MSI-H GC 分别占未选择的散发性 CRC 和 GC 的 11.9%和 8.0%。MSI-H CRC 具有发病早、右侧位置、低分化、黏液肿瘤、浸润少、淋巴转移少、家族性肿瘤多的特点。MSI-H GC 仅表现为胃窦部位的部位偏好和较少的淋巴转移。6/36 例 MSI-H CRC 和 0/23 例 MSI-H GC 主要错配修复基因病理突变的遗传和表观遗传分析呈阳性,7/36 例 MSI-H CRC 和 18/23 例 MSI-H GC 中 hMLH1 启动子甲基化(P<0.01)。
尽管 MSI-H CRC 和 MSI-H GC 的遗传基础和临床病理特征存在许多差异,但与微卫星稳定(MSS)相比,部位偏好和淋巴转移是两种 MSI-H 肿瘤的共同特征。